Loading…
This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.
Lobbying Spend
$5.7M
Filings
33
Firms Hired
1
Active Period
2018–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Client expense: $330,000 · Firm income: —
Matched citations: H.R.8267
Old Drugs, New Cures Act
2025 · fourth_quarter · Firm: BAUSCH HEALTH COMPANIES
General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Client expense: $160,000 · Firm income: —
Matched citations: H.R.8267
General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Client expense: $160,000 · Firm income: —
Matched citations: H.R.8267
Old Drugs, New Cures Act
2025 · second_quarter · Firm: BAUSCH HEALTH COMPANIES
General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Client expense: $160,000 · Firm income: —
Matched citations: H.R.8267
General issues related to health care and pharmaceuticals; drug pricing; patent reform; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Client expense: $280,000 · Firm income: —
Matched citations: H.R.8267
Old Drugs, New Cures Act
2024 · fourth_quarter · Firm: BAUSCH HEALTH COMPANIES
General issues related to health care and pharmaceuticals; drug pricing; patent reform; eye health issues; Medicare issues, including drug price negotiations; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Client expense: $160,000 · Firm income: —
Matched citations: H.R.8267
General issues related to health care and pharmaceuticals; drug pricing; patent reform; eye health issues; Medicare issues; FDA issues; FTC issues; H.R.8267 - Old Drugs, New Cures Act
Client expense: $160,000 · Firm income: —
Matched citations: H.R.8267
Source: Senate LDA